Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.
Hosted on Acast. See acast.com/privacy for more information.
php/*
Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.
Hosted on Acast. See acast.com/privacy for more information.
Copyright: © 2019 Springer Nature 878632
Henri Termeer discusses his path to Genzyme, the approval of Ceredase and the drawn-out negotiations with eventual acquirer Sanofi.
Hosted on Acast. See acast.com/privacy for more information.